Sign in

CIK 0001806540

Lycia Therapeutics, Inc.

Sign in to watch
Ticker
LYCA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
other
EIN
843860514
Phone
(650) 392-3357
Business address
400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market buy 10% owner bought 8,305 shares at $26.95 ($223,820)
  2. 4 Open-market buy 10% owner bought 25,004 shares at an average $25.78 ($644,711)
  3. 4 Conversion 10% owner acquired 7,025,307 shares (conversion)
  4. 4 Open-market buy 10% owner bought 2,045,440 shares at an average $18.41 ($37,653,863)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 1 of 2 · 24 filings